Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score

DSpace/Manakin Repository

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score
 
Schaule, Jana; Kroeze, Stephanie G C; Blanck, Oliver; Stera, Susanne; Kahl, Klaus H; Roeder, Falk; Combs, Stephanie E; Kaul, David; Claes, An; Schymalla, Markus M; Adebahr, Sonja; Eckert, Franziska; Lohaus, Fabian; Abbasi-Senger, Nasrin; Henke, Guido; Szuecs, Marcella; Geier, Michael; Sundahl, Nora; Buergy, Daniel; Dummer, Reinhard; Guckenberger, Matthias
(2020) Radiation Oncology [E], volume 15, issue 1, pp. 1 - 2
(Comment)
Abstract
An amendment to this paper has been published and can be accessed via the original article. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Oncology, Radiology Nuclear Medicine and imaging, Published Erratum
DOI: https://doi.org/10.1186/s13014-020-01708-y
ISSN: 1748-717X
Publisher: BioMed Central
Note: Publisher Copyright: © 2020, The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
(Peer reviewed)